Canaccord Raises Meta Price Target to $950

Analyst: Maria Ripps 1 min read Reproduced verbatim
Rating
Buy
Target
$950
from $930 (+2%)
Upside
+59%
META at $596 today

Canaccord Genuity’s latest target on Meta is now $950 (Oct 26, 2026); the median of 33 firms is $850.

Canaccord Genuity and Meta logos

What the analyst said

Canaccord analyst Maria Ripps raised the price target on Meta Platforms Inc. (NASDAQ: META) to $950 (from $930) while maintaining a Buy rating.

“We came away from Meta Connect even more constructive on Muse, as Meta added a growing list of retail partners and new ways to reach the agent through its glasses, a Mac app, and a small dedicated device ahead of rival launches. Early adoption has been strong, with Sensor Tower estimating that Muse passed 2.5 million downloads in its first two weeks, while the stock has rallied more than 40% in the past month.

We expect the shares to keep re-rating higher as Muse demonstrates that Meta’s model and infrastructure spending can support a product that earns from subscriptions and, over time, transaction fees, with advertising as additional optionality.

We do not expect that path to be linear, however, since competitors are preparing consumer agents of their own, including OpenAI, which hired the creator of the open-source OpenClaw agent earlier this year to build personal agents, as well as Anthropic and Google, which continue to extend Claude Cowork and Gemini toward everyday tasks.

Muse’s early lead has come without direct competition, since none of those companies has yet launched a comparable consumer agent, and we expect competitor launches to test investor confidence in Muse’s positioning. In our view, Meta’s reach across its apps, together with an advertising business that can fund a free agent for years, gives it room to keep Muse’s fees low while stand-alone AI developers may face pressure to monetize their agents sooner. We increase our PT to $950 (from $930) and maintain our BUY rating.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

META trades at $596. The 33 analysts who set a target in the last 3 months range from $650 to $1,000, with a median of $850. This $950 target is 12% above the median.

Since the note META has moved −23% (from $778). 12-month window: day 55 of 365, closes on September 25, 2027.

Track record

This callOpen: META has not reached $950 yet. This 12-month target is scored on September 25, 2027.

Firm track recordCanaccord Genuity: 56% of its 9 targets at least a year old were reached within 12 months; on Meta, 0 of 3. Accuracy ranking →

Canaccord Genuity on Meta

Canaccord Genuity price targets on Meta

8 calls from July 31, 2025 to October 26, 2026. The target went from $900 to $950 (+6%). The rating stayed Buy.

Canaccord Genuity targetMETA share price
  1. October 26, 2026Kept the $950 targetBuy$950
  2. October 22, 2026Kept the $950 targetBuy$950
  3. September 25, 2026 This noteTarget raised from $930 (+2%)Buy$950
  4. July 30, 2026Kept the $930 targetBuy$930
  5. June 4, 2026Kept the $930 targetBuy$930
  6. January 29, 2026Target raised from $900 (+3%)Buy$930
  7. September 22, 2025Kept the $900 targetBuy$900
  8. July 31, 2025Earliest call shownBuy$900
Share Reddit StockTwits
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.